ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO1044

Impact of Electrocardiographic Finding on Cardiac Mortality in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study

Session Information

Category: Hypertension and CVD

  • 1402 Hypertension and CVD: Clinical, Outcomes, and Trials


  • Hiyamuta, Hiroto, Kyushu University, Fukuoka, Not Applicable, Japan
  • Tanaka, Shigeru, Kyushu University, Fukuoka, Not Applicable, Japan
  • Taniguchi, Masatomo, Fukuoka Renal Clinic, Fukuoka, Japan
  • Nakano, Toshiaki, Kyushu University, Fukuoka, Not Applicable, Japan
  • Tsuruya, Kazuhiko, Nara Medical University, Kashihara, Japan
  • Kitazono, Takanari, Department of Medicine and Clinical Science, Fukuoka, Japan

Electrocardiography is a noninvasive and inexpensive test and regularly performed in dialysis clinic. However, its clinical predictive value in hemodialysis patients is unclear. We investigated electrocardiographic finding associated cardiac-related mortality in Japanese hemodialysis patients.


A total of 1087 Japanese HD patients aged ≥18 years who underwent electrocardiography within 1 year from baseline were followed for 10 years. Multivariate-adjusted odds ratios (OR) with 95% confidence intervals (95% CI) for electrocardiographic finding of cardiac death were calculated using logistic regression analysis. To assess the additional predictive value of electrocardiographic finding in risk assessment, we compared the c-statistics between clinical model included electrocardiographic finding and basic model.


During the follow-up period, 492 patients died totally, and 119 patients died of cardiac disease. After adjusting for confounding risk factors, heart rate (odds ratio [OR] for all cause moratality.1.46, 95% CI 1.28-1.67 for every 10/min increase), QT prolongation (OR 2.23, 95% CI 1.46-3.42), and left ventricular hypertrophy by Sokolow-Lyon voltage criteria (OR 1.81, 95% CI 1.15-2.86) was an independent predictor of cardiac-related mortality. The c-statistics of the traditional risk factors with the elcectrocardiographic findings in cardiac mortality were significantly increased compared to those of the traditional risk factors without the elcectrocardiographic findings (0.713 vs.0.753, p = 0.02).


We demonstrated electrocardiographic finding associated with all-cause and cardiac-related mortality in hemodialysis patients. Moreover, addition of the electrocardiographic finding to models with standard risk factors significantly improves the predictive ability of cardiac-related mortality.